{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:05:43Z","timestamp":1781193943520,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s40261-025-01434-x","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T06:04:33Z","timestamp":1741759473000},"page":"169-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Guanfacine Use in the ICU for Management of Sedation Weaning"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-2125","authenticated-orcid":false,"given":"Young R.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alayna","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen","family":"Kiama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"J Barr","year":"2013","unstructured":"Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263\u2013306.","journal-title":"Crit Care Med"},{"issue":"11","key":"1434_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000785","volume":"4","author":"M Fetters","year":"2022","unstructured":"Fetters M, Diep C, Ran R, Kloosterboer A. Effect of enteral guanfacine on dexmedetomidine use in the ICU. Crit Care Explor. 2022;4(11): e0785. https:\/\/doi.org\/10.1097\/CCE.0000000000000785.","journal-title":"Crit Care Explor."},{"key":"1434_CR3","unstructured":"Tilley DG, Houser SR, Koch WJ. Adrenergic agonists and antagonists. In: Brunton LL, Knollmann BC (eds) Goodman & Gilman\u2019s: the pharmacological basis of therapeutics. 14th ed. McGraw-Hill Education; 2023."},{"issue":"26","key":"1434_CR4","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","volume":"380","author":"Y Shehabi","year":"2019","unstructured":"Shehabi Y, Howe BD, Bellomo R, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med. 2019;380(26):2506\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1904710.","journal-title":"N Engl J Med"},{"issue":"1","key":"1434_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13054-017-1610-8","volume":"21","author":"JG Wang","year":"2017","unstructured":"Wang JG, Belley-Cot\u00e9 E, Burry L, et al. Clonidine for sedation in the critically ill: a systematic review and meta-analysis. Crit Care. 2017;21(1):75. https:\/\/doi.org\/10.1186\/s13054-017-1610-8.","journal-title":"Crit Care"},{"issue":"1","key":"1434_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5492\/wjccm.v12.i1.18","volume":"12","author":"S Rajendraprasad","year":"2023","unstructured":"Rajendraprasad S, Wheeler M, Wieruszewski E, et al. Clonidine use during dexmedetomidine weaning: a systematic review. World J Crit Care Med. 2023;12(1):18\u201328. https:\/\/doi.org\/10.5492\/wjccm.v12.i1.18.","journal-title":"World J Crit Care Med."},{"issue":"1","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0960327112454896","volume":"32","author":"A Kukoyi","year":"2013","unstructured":"Kukoyi A, Coker S, Lewis L, Nierenberg D. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: report of cases and review of the literature. Hum Exp Toxicol. 2013;32(1):107\u201310. https:\/\/doi.org\/10.1177\/0960327112454896.","journal-title":"Hum Exp Toxicol"},{"key":"1434_CR8","unstructured":"Sud P, Lee DC. Sedative-hypnotics. In: Nelson LS, Howland M, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS (eds) Goldfrank\u2019s toxicologic emergencies. McGraw Hill Education; 2019."},{"issue":"7","key":"1434_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00134-022-06660-x","volume":"48","author":"MH Moller","year":"2022","unstructured":"Moller MH, Alhazzani W, Lewis K, et al. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline. Intensive Care Med. 2022;48(7):801\u201310. https:\/\/doi.org\/10.1007\/s00134-022-06660-x.","journal-title":"Intensive Care Med"},{"issue":"8","key":"1434_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","volume":"56","author":"MAS Weerink","year":"2017","unstructured":"Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893\u2013913. https:\/\/doi.org\/10.1007\/s40262-017-0507-7.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1434_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/08971900241263171","volume":"38","author":"A Schuler","year":"2025","unstructured":"Schuler A, Yoon C, Caffarini E, et al. Alpha-2 agonist use in critically ill adults: a focus on sedation and withdrawal prevention. J Pharm Pract. 2025;38(1):155\u201367. https:\/\/doi.org\/10.1177\/08971900241263171.","journal-title":"J Pharm Pract"},{"issue":"5","key":"1434_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/15563650.2014.898770","volume":"52","author":"JA Lowry","year":"2014","unstructured":"Lowry JA, Brown JT. Significance of the imidazoline receptors in toxicology. Clin Toxicol (Phila). 2014;52(5):454\u201369. https:\/\/doi.org\/10.3109\/15563650.2014.898770.","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"1434_CR13","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.chest.2021.06.002","volume":"160","author":"JA Palakshappa","year":"2021","unstructured":"Palakshappa JA, Hough CL. How we prevent and treat delirium in the ICU. Chest. 2021;160(4):1326\u201334. https:\/\/doi.org\/10.1016\/j.chest.2021.06.002.","journal-title":"Chest"},{"issue":"4","key":"1434_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1089253218768537","volume":"22","author":"H Srour","year":"2018","unstructured":"Srour H, Pandya K, Flannery A, et al. Enteral guanfacine to treat severe anxiety and agitation complicating critical care after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2018;22(4):403\u20136. https:\/\/doi.org\/10.1177\/1089253218768537.","journal-title":"Semin Cardiothorac Vasc Anesth."},{"issue":"1","key":"1434_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/01.ccm.0000810144.19763.5c","volume":"50","author":"M Medley","year":"2022","unstructured":"Medley M, Wiss A, Bibb B. 955: guanfacine to aid in weaning dexmedetomidine for sedation in the ICU. Crit Care Med. 2022;50(1):474. https:\/\/doi.org\/10.1097\/01.ccm.0000810144.19763.5c.","journal-title":"Crit Care Med"},{"issue":"10","key":"1434_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7860\/JCDR\/2014\/9624.4946","volume":"8","author":"S Naaz","year":"2014","unstructured":"Naaz S, Ozair E. Dexmedetomidine in current anaesthesia practice: a review. J Clin Diagn Res. 2014;8(10):1\u20134. https:\/\/doi.org\/10.7860\/JCDR\/2014\/9624.4946.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"1434_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4103\/0970-9185.74581","volume":"26","author":"S Jamadarkhana","year":"2010","unstructured":"Jamadarkhana S, Gopal S. Clonidine in adults as a sedative agent in the intensive care unit. J Anaesthesiol Clin Pharmacol. 2010;26(4):439\u201345.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"3","key":"1434_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/ndt.s1711","volume":"4","author":"BC Strange","year":"2008","unstructured":"Strange BC. Once-daily treatment of ADHD with guanfacine: patient implications. Neuropsychiatr Dis Treat. 2008;4(3):499\u2013506. https:\/\/doi.org\/10.2147\/ndt.s1711.","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01434-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01434-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01434-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T04:59:37Z","timestamp":1744001977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01434-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01434-x","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"3 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Young R. Lee, Alayna Garza, and Laureen Kiama have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"YL: conceptualization, reviewing, and editing; AG and LK: original draft preparation, reviewing, and editing. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}